Electrophysiological effects of risperidone in mammalian cardiac cells View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-07-25

AUTHORS

János Magyar, Tamás Bányász, Zsolt Bagi, Pál Pacher, Norbert Szentandrássy, László Fülöp, Valéria Kecskeméti, Péter P. Nánási

ABSTRACT

. In this study, the effects of risperidone, the widely used antipsychotic drug, on isolated canine ventricular myocytes and guinea-pig papillary muscles were analyzed using conventional microelectrode and whole cell voltage-clamp techniques. Risperidone concentration-dependently lengthened action potential duration in guinea-pig papillary muscles (EC50=0.29±0.02 µM) and single canine ventricular myocytes (EC50=0.48±0.14 µM). This effect was reversible, showed reverse rate dependence, and it was most prominent on the terminal portion of repolarization. No significant effect of risperidone on the resting membrane potential, action potential amplitude or maximum rate of depolarization was observed.In voltage-clamped canine ventricular myocytes risperidone caused concentration-dependent block of the rapid component of the delayed rectifier K+ current (IKr), measured as outward current tails at –40 mV, with an IC50 of 0.92±0.26 µM. Suppression of IKr was not associated with changes in activation or deactivation kinetics. High concentration of risperidone (10 µM) suppressed also the slow component of the delayed rectifier K+ current (IKs) by 9.6±1.5% at +50 mV. These effects of risperidone developed rapidly and were readily reversible. Risperidone had no significant effect on the amplitude of other K+ currents (IK1 and Ito).The inhibition of cardiac IKr current by risperidone may explain the cardiac side-effects observed occasionally with the drug. Our results suggest that risperidone displays class III antiarrhythmic properties, and as such, may produce QTc prolongation, especially in patients with long QT syndrome. Therefore, in psychotic patients having also cardiac disorders, ECG control may be suggested during risperidone therapy. More... »

PAGES

350-356

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00210-002-0595-1

DOI

http://dx.doi.org/10.1007/s00210-002-0595-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024380419

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12237749


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Action Potentials", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dogs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guinea Pigs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Vitro Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocytes, Cardiac", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillary Muscles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risperidone", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Magyar", 
        "givenName": "J\u00e1nos", 
        "id": "sg:person.01206027354.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206027354.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "B\u00e1ny\u00e1sz", 
        "givenName": "Tam\u00e1s", 
        "id": "sg:person.0772313221.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772313221.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology and Pharmacotherapy, Semmelweis University, Faculty of Medicine, 1445 Budapest, P.O. Box 370, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.11804.3c", 
          "name": [
            "Department of Pharmacology and Pharmacotherapy, Semmelweis University, Faculty of Medicine, 1445 Budapest, P.O. Box 370, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bagi", 
        "givenName": "Zsolt", 
        "id": "sg:person.0627152053.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627152053.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology and Pharmacotherapy, Semmelweis University, Faculty of Medicine, 1445 Budapest, P.O. Box 370, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.11804.3c", 
          "name": [
            "Department of Pharmacology and Pharmacotherapy, Semmelweis University, Faculty of Medicine, 1445 Budapest, P.O. Box 370, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pacher", 
        "givenName": "P\u00e1l", 
        "id": "sg:person.0723772600.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723772600.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Szentandr\u00e1ssy", 
        "givenName": "Norbert", 
        "id": "sg:person.0741603700.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741603700.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "F\u00fcl\u00f6p", 
        "givenName": "L\u00e1szl\u00f3", 
        "id": "sg:person.01331745466.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331745466.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology and Pharmacotherapy, Semmelweis University, Faculty of Medicine, 1445 Budapest, P.O. Box 370, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.11804.3c", 
          "name": [
            "Department of Pharmacology and Pharmacotherapy, Semmelweis University, Faculty of Medicine, 1445 Budapest, P.O. Box 370, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kecskem\u00e9ti", 
        "givenName": "Val\u00e9ria", 
        "id": "sg:person.0606341366.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606341366.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary", 
          "id": "http://www.grid.ac/institutes/grid.7122.6", 
          "name": [
            "Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "N\u00e1n\u00e1si", 
        "givenName": "P\u00e9ter P.", 
        "id": "sg:person.0724365203.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724365203.35"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2002-07-25", 
    "datePublishedReg": "2002-07-25", 
    "description": "Abstract. In this study, the effects of risperidone, the widely used antipsychotic drug, on isolated canine ventricular myocytes and guinea-pig papillary muscles were analyzed using conventional microelectrode and whole cell voltage-clamp techniques. Risperidone concentration-dependently lengthened action potential duration in guinea-pig papillary muscles (EC50=0.29\u00b10.02\u00a0\u00b5M) and single canine ventricular myocytes (EC50=0.48\u00b10.14\u00a0\u00b5M). This effect was reversible, showed reverse rate dependence, and it was most prominent on the terminal portion of repolarization. No significant effect of risperidone on the resting membrane potential, action potential amplitude or maximum rate of depolarization was observed.In voltage-clamped canine ventricular myocytes risperidone caused concentration-dependent block of the rapid component of the delayed rectifier K+ current (IKr), measured as outward current tails at \u201340\u00a0mV, with an IC50 of 0.92\u00b10.26\u00a0\u00b5M. Suppression of IKr was not associated with changes in activation or deactivation kinetics. High concentration of risperidone (10\u00a0\u00b5M) suppressed also the slow component of the delayed rectifier K+ current (IKs) by 9.6\u00b11.5% at +50\u00a0mV. These effects of risperidone developed rapidly and were readily reversible. Risperidone had no significant effect on the amplitude of other K+ currents (IK1 and Ito).The inhibition of cardiac IKr current by risperidone may explain the cardiac side-effects observed occasionally with the drug. Our results suggest that risperidone displays class III antiarrhythmic properties, and as such, may produce QTc prolongation, especially in patients with long QT syndrome. Therefore, in psychotic patients having also cardiac disorders, ECG control may be suggested during risperidone therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00210-002-0595-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1015404", 
        "issn": [
          "0028-1298", 
          "1432-1912"
        ], 
        "name": "Naunyn-Schmiedeberg's Archives of Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "366"
      }
    ], 
    "keywords": [
      "guinea-pig papillary muscles", 
      "effects of risperidone", 
      "canine ventricular myocytes", 
      "papillary muscles", 
      "ventricular myocytes", 
      "class III antiarrhythmic properties", 
      "concentration-dependent block", 
      "whole cell voltage-clamp technique", 
      "reverse rate dependence", 
      "action potential amplitude", 
      "action potential duration", 
      "voltage-clamp technique", 
      "long QT syndrome", 
      "single canine ventricular myocytes", 
      "mammalian cardiac cells", 
      "risperidone therapy", 
      "QTc prolongation", 
      "ECG control", 
      "electrophysiological effects", 
      "antiarrhythmic properties", 
      "antipsychotic drugs", 
      "potential duration", 
      "IKr current", 
      "potential amplitude", 
      "risperidone concentrations", 
      "risperidone", 
      "psychotic patients", 
      "cardiac disorders", 
      "QT syndrome", 
      "rapid component", 
      "conventional microelectrodes", 
      "outward current tail", 
      "cardiac cells", 
      "patients", 
      "significant effect", 
      "myocytes", 
      "drugs", 
      "muscle", 
      "membrane potential", 
      "slow component", 
      "deactivation kinetics", 
      "current tail", 
      "terminal portion", 
      "syndrome", 
      "therapy", 
      "IKr", 
      "repolarization", 
      "prolongation", 
      "disorders", 
      "effect", 
      "high concentrations", 
      "depolarization", 
      "inhibition", 
      "duration", 
      "IC50", 
      "activation", 
      "cells", 
      "suppression", 
      "concentration", 
      "control", 
      "study", 
      "maximum rate", 
      "microelectrodes", 
      "rate", 
      "amplitude", 
      "changes", 
      "mV", 
      "portion", 
      "components", 
      "potential", 
      "results", 
      "block", 
      "technique", 
      "tail", 
      "current", 
      "kinetics", 
      "rectifier", 
      "rate dependence", 
      "properties", 
      "dependence", 
      "cell voltage-clamp techniques", 
      "voltage-clamped canine ventricular myocytes risperidone", 
      "canine ventricular myocytes risperidone", 
      "ventricular myocytes risperidone", 
      "myocytes risperidone", 
      "Suppression of IKr", 
      "cardiac IKr current", 
      "risperidone displays class III antiarrhythmic properties", 
      "displays class III antiarrhythmic properties", 
      "III antiarrhythmic properties"
    ], 
    "name": "Electrophysiological effects of risperidone in mammalian cardiac cells", 
    "pagination": "350-356", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024380419"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00210-002-0595-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12237749"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00210-002-0595-1", 
      "https://app.dimensions.ai/details/publication/pub.1024380419"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_361.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00210-002-0595-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00210-002-0595-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00210-002-0595-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00210-002-0595-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00210-002-0595-1'


 

This table displays all metadata directly associated to this object as RDF triples.

248 TRIPLES      21 PREDICATES      127 URIs      119 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00210-002-0595-1 schema:about N2ea8697f392f43ef9ddba524682e96e0
2 N57ed757227544b1d864379be25d9f171
3 N5d7313eb2a57401b9273f348b1b52031
4 N8535f79a5e5f4ffa97aea31e64230093
5 N8e71df531dde42a5bb06d6df2a46be78
6 N8f3ee307222b443caa124a0265c41dfe
7 N9a3d5bdcaf6c4b7285059248d5c4a14c
8 N9a3f90b1b9fa43e2af21b66a46d2ea42
9 N9e9a1a9ffee6459e80e9efbdab7d77e2
10 Nd283653cbe284bd1948acd3ff43c2db8
11 Nf95ff14fd7f44e50b784890691ec8962
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author Nc42f982b99e0458db8aaf89ac77c7dec
15 schema:datePublished 2002-07-25
16 schema:datePublishedReg 2002-07-25
17 schema:description Abstract. In this study, the effects of risperidone, the widely used antipsychotic drug, on isolated canine ventricular myocytes and guinea-pig papillary muscles were analyzed using conventional microelectrode and whole cell voltage-clamp techniques. Risperidone concentration-dependently lengthened action potential duration in guinea-pig papillary muscles (EC50=0.29±0.02 µM) and single canine ventricular myocytes (EC50=0.48±0.14 µM). This effect was reversible, showed reverse rate dependence, and it was most prominent on the terminal portion of repolarization. No significant effect of risperidone on the resting membrane potential, action potential amplitude or maximum rate of depolarization was observed.In voltage-clamped canine ventricular myocytes risperidone caused concentration-dependent block of the rapid component of the delayed rectifier K+ current (IKr), measured as outward current tails at –40 mV, with an IC50 of 0.92±0.26 µM. Suppression of IKr was not associated with changes in activation or deactivation kinetics. High concentration of risperidone (10 µM) suppressed also the slow component of the delayed rectifier K+ current (IKs) by 9.6±1.5% at +50 mV. These effects of risperidone developed rapidly and were readily reversible. Risperidone had no significant effect on the amplitude of other K+ currents (IK1 and Ito).The inhibition of cardiac IKr current by risperidone may explain the cardiac side-effects observed occasionally with the drug. Our results suggest that risperidone displays class III antiarrhythmic properties, and as such, may produce QTc prolongation, especially in patients with long QT syndrome. Therefore, in psychotic patients having also cardiac disorders, ECG control may be suggested during risperidone therapy.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf Ndec79d77e9474a31b15d2f0adf58fb04
22 Nff78cce5cd0440ff895da22a6d6252a5
23 sg:journal.1015404
24 schema:keywords ECG control
25 IC50
26 III antiarrhythmic properties
27 IKr
28 IKr current
29 QT syndrome
30 QTc prolongation
31 Suppression of IKr
32 action potential amplitude
33 action potential duration
34 activation
35 amplitude
36 antiarrhythmic properties
37 antipsychotic drugs
38 block
39 canine ventricular myocytes
40 canine ventricular myocytes risperidone
41 cardiac IKr current
42 cardiac cells
43 cardiac disorders
44 cell voltage-clamp techniques
45 cells
46 changes
47 class III antiarrhythmic properties
48 components
49 concentration
50 concentration-dependent block
51 control
52 conventional microelectrodes
53 current
54 current tail
55 deactivation kinetics
56 dependence
57 depolarization
58 disorders
59 displays class III antiarrhythmic properties
60 drugs
61 duration
62 effect
63 effects of risperidone
64 electrophysiological effects
65 guinea-pig papillary muscles
66 high concentrations
67 inhibition
68 kinetics
69 long QT syndrome
70 mV
71 mammalian cardiac cells
72 maximum rate
73 membrane potential
74 microelectrodes
75 muscle
76 myocytes
77 myocytes risperidone
78 outward current tail
79 papillary muscles
80 patients
81 portion
82 potential
83 potential amplitude
84 potential duration
85 prolongation
86 properties
87 psychotic patients
88 rapid component
89 rate
90 rate dependence
91 rectifier
92 repolarization
93 results
94 reverse rate dependence
95 risperidone
96 risperidone concentrations
97 risperidone displays class III antiarrhythmic properties
98 risperidone therapy
99 significant effect
100 single canine ventricular myocytes
101 slow component
102 study
103 suppression
104 syndrome
105 tail
106 technique
107 terminal portion
108 therapy
109 ventricular myocytes
110 ventricular myocytes risperidone
111 voltage-clamp technique
112 voltage-clamped canine ventricular myocytes risperidone
113 whole cell voltage-clamp technique
114 schema:name Electrophysiological effects of risperidone in mammalian cardiac cells
115 schema:pagination 350-356
116 schema:productId N376775a323a4462990b2889c95750c7e
117 N7e4b9628531046729318bbb3a51a1a96
118 Nb6145eb097df4c3597d76a6f716660a2
119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024380419
120 https://doi.org/10.1007/s00210-002-0595-1
121 schema:sdDatePublished 2022-01-01T18:12
122 schema:sdLicense https://scigraph.springernature.com/explorer/license/
123 schema:sdPublisher Ne43c6f59344f46e7bd01b7c53e8a6898
124 schema:url https://doi.org/10.1007/s00210-002-0595-1
125 sgo:license sg:explorer/license/
126 sgo:sdDataset articles
127 rdf:type schema:ScholarlyArticle
128 N19bf294efd6b40dd8d7567b60a087ee2 rdf:first sg:person.0724365203.35
129 rdf:rest rdf:nil
130 N2ea8697f392f43ef9ddba524682e96e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Risperidone
132 rdf:type schema:DefinedTerm
133 N376775a323a4462990b2889c95750c7e schema:name pubmed_id
134 schema:value 12237749
135 rdf:type schema:PropertyValue
136 N42c478ac78e543c8b40b82155d8588ff rdf:first sg:person.0772313221.04
137 rdf:rest N44a3fac19df14f67b88f3aed2869f52d
138 N44a3fac19df14f67b88f3aed2869f52d rdf:first sg:person.0627152053.26
139 rdf:rest Nb9160bbb0b63463295673a3c0df9103e
140 N4780432bf9ab479eb5d4865ff3e14c80 rdf:first sg:person.01331745466.46
141 rdf:rest Nccb56e72b2fe458fa34477216fbf2eed
142 N57ed757227544b1d864379be25d9f171 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Male
144 rdf:type schema:DefinedTerm
145 N5d7313eb2a57401b9273f348b1b52031 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Cells, Cultured
147 rdf:type schema:DefinedTerm
148 N7e4b9628531046729318bbb3a51a1a96 schema:name dimensions_id
149 schema:value pub.1024380419
150 rdf:type schema:PropertyValue
151 N8535f79a5e5f4ffa97aea31e64230093 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Animals
153 rdf:type schema:DefinedTerm
154 N8e71df531dde42a5bb06d6df2a46be78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Myocytes, Cardiac
156 rdf:type schema:DefinedTerm
157 N8f3ee307222b443caa124a0265c41dfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name In Vitro Techniques
159 rdf:type schema:DefinedTerm
160 N9a3d5bdcaf6c4b7285059248d5c4a14c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Papillary Muscles
162 rdf:type schema:DefinedTerm
163 N9a3f90b1b9fa43e2af21b66a46d2ea42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Action Potentials
165 rdf:type schema:DefinedTerm
166 N9e9a1a9ffee6459e80e9efbdab7d77e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Guinea Pigs
168 rdf:type schema:DefinedTerm
169 Nb6145eb097df4c3597d76a6f716660a2 schema:name doi
170 schema:value 10.1007/s00210-002-0595-1
171 rdf:type schema:PropertyValue
172 Nb9160bbb0b63463295673a3c0df9103e rdf:first sg:person.0723772600.74
173 rdf:rest Nde3b0c37ba5d489bbdecd32328d3f1b4
174 Nc42f982b99e0458db8aaf89ac77c7dec rdf:first sg:person.01206027354.83
175 rdf:rest N42c478ac78e543c8b40b82155d8588ff
176 Nccb56e72b2fe458fa34477216fbf2eed rdf:first sg:person.0606341366.10
177 rdf:rest N19bf294efd6b40dd8d7567b60a087ee2
178 Nd283653cbe284bd1948acd3ff43c2db8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Dogs
180 rdf:type schema:DefinedTerm
181 Nde3b0c37ba5d489bbdecd32328d3f1b4 rdf:first sg:person.0741603700.70
182 rdf:rest N4780432bf9ab479eb5d4865ff3e14c80
183 Ndec79d77e9474a31b15d2f0adf58fb04 schema:issueNumber 4
184 rdf:type schema:PublicationIssue
185 Ne43c6f59344f46e7bd01b7c53e8a6898 schema:name Springer Nature - SN SciGraph project
186 rdf:type schema:Organization
187 Nf95ff14fd7f44e50b784890691ec8962 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Dose-Response Relationship, Drug
189 rdf:type schema:DefinedTerm
190 Nff78cce5cd0440ff895da22a6d6252a5 schema:volumeNumber 366
191 rdf:type schema:PublicationVolume
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
196 schema:name Clinical Sciences
197 rdf:type schema:DefinedTerm
198 sg:journal.1015404 schema:issn 0028-1298
199 1432-1912
200 schema:name Naunyn-Schmiedeberg's Archives of Pharmacology
201 schema:publisher Springer Nature
202 rdf:type schema:Periodical
203 sg:person.01206027354.83 schema:affiliation grid-institutes:grid.7122.6
204 schema:familyName Magyar
205 schema:givenName János
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206027354.83
207 rdf:type schema:Person
208 sg:person.01331745466.46 schema:affiliation grid-institutes:grid.7122.6
209 schema:familyName Fülöp
210 schema:givenName László
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331745466.46
212 rdf:type schema:Person
213 sg:person.0606341366.10 schema:affiliation grid-institutes:grid.11804.3c
214 schema:familyName Kecskeméti
215 schema:givenName Valéria
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606341366.10
217 rdf:type schema:Person
218 sg:person.0627152053.26 schema:affiliation grid-institutes:grid.11804.3c
219 schema:familyName Bagi
220 schema:givenName Zsolt
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627152053.26
222 rdf:type schema:Person
223 sg:person.0723772600.74 schema:affiliation grid-institutes:grid.11804.3c
224 schema:familyName Pacher
225 schema:givenName Pál
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723772600.74
227 rdf:type schema:Person
228 sg:person.0724365203.35 schema:affiliation grid-institutes:grid.7122.6
229 schema:familyName Nánási
230 schema:givenName Péter P.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724365203.35
232 rdf:type schema:Person
233 sg:person.0741603700.70 schema:affiliation grid-institutes:grid.7122.6
234 schema:familyName Szentandrássy
235 schema:givenName Norbert
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741603700.70
237 rdf:type schema:Person
238 sg:person.0772313221.04 schema:affiliation grid-institutes:grid.7122.6
239 schema:familyName Bányász
240 schema:givenName Tamás
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772313221.04
242 rdf:type schema:Person
243 grid-institutes:grid.11804.3c schema:alternateName Department of Pharmacology and Pharmacotherapy, Semmelweis University, Faculty of Medicine, 1445 Budapest, P.O. Box 370, Hungary
244 schema:name Department of Pharmacology and Pharmacotherapy, Semmelweis University, Faculty of Medicine, 1445 Budapest, P.O. Box 370, Hungary
245 rdf:type schema:Organization
246 grid-institutes:grid.7122.6 schema:alternateName Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary
247 schema:name Department of Physiology, University Medical School of Debrecen, 4012 Debrecen, P.O. Box 22, Hungary
248 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...